Top Dutch (AEX) Growth Stocks

Top Dutch (AEX) Growth Stocks

UPDATED Jun 29, 2022

What are the best Dutch (AEX) Growth Stocks?

According to our Simply Wall St analysis these are the best Dutch growth companies. We look for companies with high forecasted growth and healthy balance sheets that can deliver sustained growth over the long term.

Our criteria to find Top Growth Companies

Growth

  • Companies with sustained revenue growth that outperforms the market are attractive to investors. These companies are most likely to appreciate in share price over time.

What do we look for?

  • Is the company forecast to have high earnings growth.

Healthy Balance Sheet

  • A healthy balance sheet is essential to drive growth opportunities and sustain the business.
  • Repayments on debt take precedence over other initiatives to improve shareholder returns, so investors want to make sure the company is comfortably positioned to cover its debts.

What do we look for?

  • Does the company have a manageable level of debt.
  • Is the company able to cover its interest repayments.

3 companies meet this criteria in the Dutch market

Beter Bed Holding N.V. retails and wholesales bedroom furnishing products in the Netherlands and Belgium.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: BBED's earnings are expected to grow significantly over the next 3 years.

  • Revenue vs Market

  • Future ROE

  • High Growth Revenue

See Full Stock Report

Rewards

  • Trading at 68.9% below our estimate of its fair value

  • Earnings are forecast to grow 22.04% per year

Risks

  • Shareholders have been diluted in the past year

View all Risks and Rewards

Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: PHARM's earnings are expected to grow significantly over the next 3 years.

  • Revenue vs Market

  • Future ROE

  • High Growth Revenue

See Full Stock Report

Rewards

  • Trading at 81.9% below our estimate of its fair value

  • Earnings are forecast to grow 34.6% per year

Risks

  • Profit margins (5.4%) are lower than last year (18.4%)

  • Large one-off items impacting financial results

View all Risks and Rewards

PB Holding N.V. operates as an automotive retail and services company in the Netherlands.

Growth Criteria

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings: PBH's earnings are expected to grow significantly over the next 3 years.

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

See Full Stock Report

Rewards

  • Trading at 68.3% below our estimate of its fair value

  • Earnings are forecast to grow 60.75% per year

Risks

  • Makes less than USD$1m in revenue (€0)

  • Does not have a meaningful market cap (€18M)

View all Risks and Rewards
Page 1 of 1